Home > Journals > Minerva Pediatrics > Past Issues > Minerva Pediatrica 2020 December;72(6) > Minerva Pediatrica 2020 December;72(6):514-22

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Pediatrica 2020 December;72(6):514-22

DOI: 10.23736/S0026-4946.20.06002-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Fecal calprotectin in the pediatric population: a 2020 update

Fabio CISARÒ , Antonio PIZZOL, Caterina RIGAZIO, Pier L. CALVO

Unit of Pediatric Gastroenterology, Department of Pediatrics, Città della Salute e della Scienza, Turin, Italy



Calprotectin is a calcium and zinc-binding protein, formed by a hetero complex of S100A8 and S100A9 proteins, which belong to the S-100 protein family consisting in more than 20 different proteins with a tissue-specific expression pattern. This protein is secreted extracellularly from stimulated neutrophils or released by cell disruption or death. The presence of calprotectin in feces quantitatively relates to neutrophil migration toward the gastrointestinal (GI) tract; thus, it represents a useful marker of intestinal inflammation. Fecal calprotectin (FC) has been proven largely useful for determining the inflammatory origin of GI symptoms differentiating between organic and non-organic diseases. Indeed, increased FC levels are also seen in gastroenteritis, microscopic colitis, polyps, malignancies and cystic fibrosis. To date, there are many evidences regarding usefulness in the detection of fecal calprotectin for the management of gastrointestinal disorders, both in children and adults but, especially in the pediatric population, still clear indications for its use are lacking. Its incorporation in primary care reduces the risk of missing an organic disease and facilitates the indication for expensive and invasive investigations as colonoscopy. We herein review and discuss the last evidence on the usefulness of FC in children, with its current indications and future prospective.


KEY WORDS: Leukocyte L1 antigen complex; Feces; Pediatrics; Gastrointestinal disesases

top of page